Benzyl Salicylate & Citral EU Restriction 2026: New Fragrance Limits and Compliance Rules Explained 

Benzyl salicylate and citral are two of the most widely used fragrance ingredients in cosmetics, but under the benzyl salicylate citral EU restriction 2026, brands are now facing significantly tighter controls. The new fragrance allergen limits EU 2026, introduced through Regulation 2026/909, have changed how these ingredients must be assessed, calculated, and documented in cosmetic formulations.

Compliance depends on precise citral concentration data for cosmetics, product-specific exposure limits, and updated allergen risk assessments within the fragrance allergen CPSR. 

Even brands that rely on IFRA-standard cosmetics for fragrance compliance are discovering that IFRA alignment does not automatically guarantee EU regulatory approval.

From leave-on skincare to perfumes and essential oil-based formulations, every product containing benzyl salicylate or citral now requires a more detailed safety and regulatory review before the 1 January 2027 enforcement deadline. 

This guide explains the new Benzyl Salicylate and Citral restrictions, SCCS safety findings, Annex III requirements, concentration limits by product category, compliance deadlines, and the practical steps needed to keep cosmetic products legally compliant in both the EU and UK markets. 

What Changed Under Regulation (EU) 2026/909 Fragrance Rules

Here’s the fast version for anyone who needs the headline changes first:

• Benzyl salicylate now has product-specific maximum concentration limits, no more single general threshold
• Citral limits now apply based on product exposure scenarios, not just a blanket restriction
• Geranial and neral (citral’s two components) have their own dedicated transitional deadlines, slightly different from citral generally
• Existing fragrance allergen labeling thresholds (0.001% leave-on / 0.01% rinse-off) remain unchanged
• Non-compliant products cannot be newly placed on the EU market after 1 January 2027
• Products already in the supply chain must be fully cleared by July or August 2028, depending on the substance

That’s the core of it. Everything below explains the details behind each of those points.

Why the EU Updated Benzyl Salicylate and Citral Restrictions

The old rules treated fragrance allergens with relatively broad limits, one threshold, applied generally, regardless of whether the product was a rinse-off shampoo or a leave-on face cream. That approach worked as a starting point, but it didn’t account for real-world exposure differences between product types.

The fragrance allergen limits EU 2026 update is the EU acting on what the science actually shows. The SCCS re-evaluated how much benzyl salicylate and citral consumers realistically absorb across different product categories, and the results showed that leave-on products, face products, and oral care products meaningfully carried higher exposure than rinse-off formats. A one-size limit couldn’t adequately protect consumers across all those categories at the same time.

So the Commission moved to exposure-based, product-specific limits. That’s the logic behind why the face make-up limit (0.2%) is so much tighter than the perfume limit (4%), it’s not arbitrary. It reflects the difference in how those products are used every single day.

What Did the SCCS Find About Benzyl Salicylate and Citral?

The Scientific Committee on Consumer Safety (SCCS) is the body whose opinions drive EU cosmetic ingredient decisions, and its evaluations of benzyl salicylate and citral were thorough. Here’s what the evidence showed:

Sensitization potential. Both ingredients are classified as skin sensitizers. That means repeated exposure, even at low levels, can trigger an immune response in some people, leading to allergic contact dermatitis. Once sensitization occurs, even trace amounts can cause reactions.

Aggregate exposure concern. The SCCS looked at consumers who use multiple products containing these ingredients simultaneously, body lotion, perfume, and shampoo, all in the same routine. Aggregate exposure across a full daily routine was significantly higher than single-product exposure models suggested. 

Leave-on product risk. Products that stay on the skin all day drive far higher systemic and local exposure than rinse-off products. The SCCS found this distinction warranted separate limits, which is exactly what the new Regulation 2026/909 fragrance update delivers.

Risk assessment methodology. The SCCS used a Quantitative Risk Assessment (QRA) approach to model realistic consumer use patterns by product type. This is the same methodology IFRA uses, but the SCCS applied it specifically to EU consumer exposure data, which doesn’t always align with IFRA’s current amendment. That’s why IFRA compliance alone doesn’t guarantee EU compliance.

Which Cosmetic Products Are Affected by the Benzyl Salicylate Citral EU Restriction 2026?

Any scented cosmetic product could be affected, but some categories carry far more risk than others. Here’s a clear breakdown:

High priority, review these first:

• Face creams and moisturizers: leave-on, high daily use, 0.2% limit
• Face make-up and make-up removers: 0.2% limit applies here too
• Body lotions: leave-on format, 0.7% limit, widely used with complex fragrance blends
• Oral care products: toothpastes, mouthwashes, lip products, the 0.004% limit is extremely tight
• Natural and essential-oil-based formulas: citral content from botanical ingredients is often underestimated

Medium priority, check but likely manageable:

• Deodorant sprays: 0.91% limit, workable for most formulas
• Shampoos and conditioners: 0.5% rinse-off limit
• Shower gels and bath products: 1.3% limit, relatively generous

Lower priority:

• Eau de parfum and eau de toilette: a 4% limit gives significant room
• Hydro-alcoholic fragrances generally have the highest permitted limit across all categories

New Benzyl Salicylate and Citral Concentration Limits by Product Type

Getting the product category classification right matters as much as the number itself. A product that straddles two categories should use the stricter limit as a conservative baseline, and your safety assessor should document that decision in the CPSR.

Old Rules vs New EU Limits for Benzyl Salicylate & Citral Under Regulation 2026/909 

The main change is moving from general limits to product-specific limits, and everything else follows from that. 

Citral Concentration in Cosmetics:

Citral is two molecules, geranial (citral A) and neral (citral B). Both are regulated. Both count toward the same product-category limit. And both occur naturally in a wide range of botanical ingredients that natural and organic brands use as standard.

Lemon oil, bergamot, lemongrass, verbena, lemon myrtle, and melissa all contain significant amounts of citral. And here’s what catches formulators out: the regulation does not differentiate between synthetic citral and citral derived from a natural source.

A face cream using 0.5% bergamot oil, which can contain 30–40% citral, could easily push the finished product’s citral content above the 0.2% limit before any other ingredient is considered. Brands positioning themselves as “natural” or “clean” are often the most exposed under the new citral concentration cosmetics rules, because their formulas tend to carry the heaviest essential oil loads.

This is not a reason to avoid natural ingredients. It’s a reason to measure them properly rather than assume.

EU Fragrance Allergen Labeling Requirement Rules:

Two separate compliance requirements apply here, and they need to be checked independently.

Maximum concentration limits (new under 2026/909): the product must not exceed these limits, regardless of labeling.

Labeling thresholds (unchanged, existing rules): the ingredient must be named on-pack whenever it exceeds:

A body lotion containing 0.5% benzyl salicylate is compliant with the concentration limit (under 0.7%). But it’s 500 times the 0.001% labeling threshold, so the ingredient name must appear in the INCI list. 

IFRA Standards Cosmetics vs EU Regulation 2026/909: 

IFRA standards, cosmetics guidelines, and EU regulatory limits share similar scientific foundations; both use QRA methodology, but they’re developed separately and don’t always land in the same place.

IFRA is an industry body, and its standards are guidelines that fragrance members voluntarily adopt. EU Regulation is law for products sold in the EU; the law governs enforcement, recalls, and legal liability.

For benzyl salicylate and citral specifically, the SCCS assessments that drove the 2026 EU limits reflected EU consumer exposure data and risk thresholds that aren’t fully replicated in IFRA’s current amendment structure. IFRA and EU rules do not always match, so brands should check both separately.

Stop accepting fragrance house certificates that only reference IFRA compliance as sufficient for fragrance allergen CPSR documentation. Your safety assessor needs to verify the limits directly against Regulation 2026/909, not through a proxy.

How to Update Your Fragrance Allergen CPSR for the New 2026 Limits

Updating the CPSR isn’t optional when a regulation changes the limits your product is assessed against. Here’s what a proper update covers:

1. Confirm actual concentrations: Not estimated, not calculated from nominal fragrance percentages. Measured or supplier-verified quantified data for benzyl salicylate and citral individually.
2. Classify the product correctly: Match the right product category to the right limit. Document the classification rationale in the report.
3. Flag reformulation need: if current levels exceed the new limit, the CPSR should clearly note this and recommend a formula revision before the January 2027 deadline.
4. Update regulatory references: the CPSR must reference the amended Annex III entries under Regulation (EU) 2026/909, not just Regulation (EC) No 1223/2009 in its prior form.
5. Check labeling compliance: Verify both the concentration limit and the labeling threshold independently, and document both in the safety assessment.
6. Re-submit CPNP notification if the formula changes: Any reformulation that changes the qualitative or quantitative composition triggers a new notification on the Cosmetic Products Notification Portal.

Benzyl Salicylate, Citral, Geranial, and Neral Compliance Deadlines: 

The January 2027 market placement deadline is the production cut-off. After that date, non-compliant products cannot legally leave your facility destined for the EU market. The 2028 dates cover stock already in the supply chain; retailers have until then to sell through existing inventory.

Most brands need 6–12 months to reformulate products, update safety assessments, and revise labels. Since it is already June 2026, there is limited time left to make these changes before regulatory deadlines take effect. 

Common Benzyl Salicylate & Citral Compliance Mistakes to Avoid

1.  Assuming natural ingredients are exempt. The regulation doesn’t distinguish origin. Citral from lemongrass oil counts the same as synthetic citral. Natural formulas are often the most at risk.
2. Using IFRA certificates as proof of EU compliance. IFRA and EU limits are not the same. An IFRA-compliant fragrance can still exceed the new EU category-specific limits.
3. Ignoring geranial and neral as separate contributors. Both contribute to total citral content. If your formula declares citral generically, make sure geranial and neral are included in the calculation; they have their own transitional deadline too.
4. Using estimated allergen percentages in the CPSR. “Approximately 0.3% citral” isn’t good enough. You need verified quantitative data from your supplier, especially for complex naturals where citral content varies batch to batch.
5. Forgetting the label update alongside the formula update. Reformulation changes the INCI list. Label artwork needs updating. These two things often run on separate tracks in a brand’s internal process, and labels get forgotten until the last minute.
6. Applying the wrong product category. A “leave-on hair product” and a “leave-on hair spray” have different limits. A “face cream” and a “body lotion” have different limits. Misclassification is a common CPSR error that can leave a product technically non-compliant even after reformulation.
7. Waiting until late 2026 to start. The January 2027 deadline sounds far away. It isn’t, not when reformulation, safety assessment, supplier sign-off, label artwork, and CPNP re-notification all need to happen in sequence.

Compliance Audit Checklist for the 2026 Fragrance Allergen Limits

Step 1: Map your affected products. Pull every product in your range that contains benzyl salicylate or citral. Include products where citral may be present through essential oils; don’t rely on INCI lists alone.

Step 2: Request quantified allergen data from suppliers. Ask for individual allergen percentages, not IFRA certificates. For essential oils, ask for measured citral content, not typical ranges.

Step 3: Calculate finished product concentrations. Apply the correct limit for your product’s category. If the product sits between categories, use the stricter limit.

Step 4: Identify what needs reformulation vs label-only fixes. Some products will already be under the new limits but will be missing the allergen name on-pack. Others need the fragrance blend changed. Separate these lists; they need different workflows.

Step 5: Commission CPSR updates. Any change to the formula triggers a full safety reassessment. Even label-only changes need to be logged in the Product Information File with regulatory references updated to 2026/909.

Step 6: Update label artwork. Include allergen labeling where thresholds are exceeded and reflect any INCI changes from reformulation.

Step 7: Re-notify on CPNP if the formula changed. Qualitative or quantitative formula changes require updated notification.

Step 8: Work backward from 1 January 2027. Map your timeline now. Reformulation → supplier sign-off → safety assessment → artwork → CPNP. 

Key Takeaways for Cosmetic Brands and Safety Assessors

The benzyl salicylate citral EU restriction 2026 is a fundamental shift in how these fragrance allergens are regulated, from broad general limits to product-specific, exposure-based concentration caps. The fragrance allergen limits EU 2026 under Regulation 2026/909 are enforceable, specific, and backed by solid SCCS science.

For brand owners: check your portfolio against the product-category limits now, get quantified supplier data, and build your reformulation timeline against January 2027, not towards it.

For safety assessors: update every affected CPSR with correct category classification, verified allergen data, and explicit reference to Regulation 2026/909. IFRA certificates alone are not sufficient documentation.

FAQs: Benzyl Salicylate & Citral EU Restriction 2026

Is benzyl salicylate banned in EU cosmetics? 

No, benzyl salicylate is not banned. It remains permitted under Regulation (EU) 2026/909 but is now subject to product-specific maximum concentration limits. The limits range from 0.004% in oral products to 4% in hydro-alcoholic fragrances, depending on the product category.

Is citral banned in cosmetics? 

Citral is not banned. Like benzyl salicylate, it is permitted under Regulation 2026/909 with new product-category-specific concentration caps. Geranial and neral, citral’s two components, are regulated under the same framework.

Do essential oils count toward citral limits? 

Essential oils are fully included in the calculation of citral limits. Citral from any source, synthetic, natural, or essential oil, counts toward the product’s total citral concentration. This is one of the most important points for natural and organic brands to understand.

Does IFRA compliance guarantee EU compliance? 

No, IFRA standards and EU regulatory limits are developed independently. In some product categories, an IFRA-compliant formula can still exceed the new EU concentration limits. EU compliance must be verified directly against Regulation 2026/909.

How do I calculate citral concentration in a finished product? 

Multiply the percentage of each raw material containing citral by that material’s known citral content, then sum across all ingredients. For example, 1% bergamot oil at 35% citral content contributes 0.35% citral to the finished product. Your fragrance supplier should provide quantified allergen declarations to make this calculation accurate.

Do I need a new CPSR after reformulation? 

Yes, Any change to the qualitative or quantitative composition of a cosmetic product, including fragrance adjustments made to meet the new limits, requires a fully updated Cosmetic Product Safety Report before the reformulated product can be placed on the market.